Quick Answer
CYTOKINETICS INC reported Diluted EPS of $6.54 per share (loss) for fiscal year 2025.
CYTOKINETICS INC Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$6.54 | -24.3% |
| 2024 | -$5.26 | +3.5% |
| 2023 | -$5.45 | -25.9% |
| 2022 | -$4.33 | -54.6% |
| 2021 | -$2.80 | -42.1% |
| 2020 | -$1.97 | +23.9% |
| 2017 | -$2.59 | -764.1% |
| 2016 | $0.39 | +140.2% |
| 2015 | -$0.97 | -136.6% |
| 2014 | -$0.41 | +43.1% |
| 2011 | -$0.72 | +6.5% |
| 2010 | -$0.77 | -283.3% |
| 2009 | $0.42 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$2.55 | -87.5% | -127.7% |
| June 30, 2025 | -$1.12 | +14.5% | +17.6% |
| March 31, 2025 | -$1.36 | -2.3% | +0.0% |
| September 30, 2024 | -$1.36 | -0.7% | -3.8% |
| June 30, 2024 | -$1.31 | +2.2% | +1.5% |
| March 31, 2024 | -$1.33 | +3.6% | +1.5% |
| September 30, 2023 | -$1.35 | +11.2% | -0.7% |
| June 30, 2023 | -$1.34 | -482.6% | +2.9% |
- CYTOKINETICS INC showed a decrease of -24.3% in Diluted EPS compared to the prior fiscal year.
- Over the 2009–2025 period, CYTOKINETICS INC’s diluted eps has declined by 1657.1% (from $0.42 per share to $6.54 per share (loss)).
- The most recent figure is from CYTOKINETICS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: